Anhui Fengyuan Pharmaceutical Co., Ltd.
Symbol: 000153.SZ
SHZ
8.55
CNYMarktpreis heute
17.7110
P/E-Verhältnis
0.1358
PEG-Verhältnis
2.84B
MRK Kapital
- 0.01%
DIV Rendite
Anhui Fengyuan Pharmaceutical Co., Ltd. (000153-SZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1104.98 | 319.9 | 353.1 | 251.3 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | -860.53 | -213.4 | 80.7 | -226.9 | |||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 4181.1 | 984.8 | 925.9 | 839.2 | |||||||||||||||||||||||||||
balance-sheet.row.inventory | 2298.35 | 573.6 | 699.1 | 569.5 | |||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 155.27 | 24.7 | 99.2 | 34.8 | |||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 7739.7 | 1902.9 | 2077.4 | 1694.8 | |||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 6019.73 | 1513.9 | 1461.7 | 1223.5 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill | 31.68 | 7.9 | 7.9 | 7.9 | |||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1126.56 | 285.6 | 244.9 | 225.8 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1158.24 | 293.5 | 252.8 | 233.7 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2388.93 | 575.8 | 566.8 | 556.4 | |||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 213.4 | 60.2 | 40 | 37.5 | |||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 162.13 | 45 | 70.6 | 70.4 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 9942.45 | 2488.4 | 2391.8 | 2121.6 | |||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-assets | 17682.15 | 4391.3 | 4469.2 | 3816.3 | |||||||||||||||||||||||||||
balance-sheet.row.account-payables | 2940.77 | 746.1 | 722.7 | 612.9 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 2171.78 | 492.8 | 598.4 | 501.1 | |||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 201.48 | 49.9 | 68.1 | 43.5 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 944.12 | 195 | 189.6 | 114 | |||||||||||||||||||||||||||
Deferred Revenue Non Current | 795.47 | 238 | 151.9 | 150.9 | |||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 104.89 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 37.21 | 10.2 | 766.3 | 15.9 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1844.48 | 458.9 | 369.8 | 338.2 | |||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 74.55 | 20.2 | 20.7 | 28 | |||||||||||||||||||||||||||
balance-sheet.row.total-liab | 10056.97 | 2472.5 | 2714.5 | 2258.6 | |||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.common-stock | 1328.27 | 332 | 332.1 | 312.1 | |||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 3532.26 | 888.7 | 764.4 | 629.3 | |||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 919.43 | 53.1 | 595.2 | 112.2 | |||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1733.96 | 615.5 | 36.8 | 474.6 | |||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 7513.92 | 1889.4 | 1728.5 | 1528.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 17682.15 | 4391.3 | 4469.2 | 3816.3 | |||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 111.26 | 29.4 | 26.3 | 29.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-equity | 7625.18 | 1918.8 | 1754.8 | 1557.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 17682.15 | - | - | - | |||||||||||||||||||||||||||
Total Investments | 1528.4 | 362.4 | 371.5 | 329.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-debt | 3115.9 | 687.8 | 788 | 615.1 | |||||||||||||||||||||||||||
balance-sheet.row.net-debt | 2010.92 | 367.9 | 434.8 | 363.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 160.27 | 150.9 | 109.5 | 102.1 | ||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 98.78 | 121.7 | 76.8 | 70.9 | ||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -11.32 | -5.7 | -10.3 | 5.6 | ||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 18.88 | 5.7 | 10.3 | -5.6 | ||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -112.36 | 121.5 | -4.6 | 73.8 | ||||||||||||||||||||||||
cash-flows.row.account-receivables | -238.77 | -89.3 | -114.1 | 44.8 | ||||||||||||||||||||||||
cash-flows.row.inventory | 126.41 | -44.9 | -42.3 | -40.7 | ||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 261.4 | 138.8 | -44.8 | ||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -5.7 | 12.9 | 114.5 | ||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 115.12 | 45.8 | 56.2 | 46 | ||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 250.48 | 0 | 0 | 0 | ||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -153.03 | -81.8 | -157.4 | -190.7 | ||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 7.94 | -302.7 | 1 | 4.3 | ||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -85 | -29 | -1 | -31.9 | ||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0.15 | 5.7 | 7.2 | 133.1 | ||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -76.6 | 308.3 | 0.4 | 0.4 | ||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -229.62 | -99.4 | -149.7 | -84.9 | ||||||||||||||||||||||||
cash-flows.row.debt-repayment | -588.23 | -804.3 | -942.9 | -1157.2 | ||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.35 | 0 | 0 | 0 | ||||||||||||||||||||||||
cash-flows.row.dividends-paid | -62.48 | -57.5 | -25.6 | -38.4 | ||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 358.44 | 599.5 | 862.5 | 985.8 | ||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 55.59 | -262.3 | -106 | -209.8 | ||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.21 | 0.1 | -0.3 | -0.6 | ||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 76.66 | 78.4 | -18.2 | -2.5 | ||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1001.66 | 344.7 | 234.6 | 252.8 | ||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 925 | 266.3 | 252.8 | 255.3 | ||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 250.48 | 440 | 237.9 | 292.8 | ||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -153.03 | -81.8 | -157.4 | -190.7 | ||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 97.45 | 358.2 | 80.5 | 102 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4189.99 | 4275.4 | 4004 | 3501.7 | |||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 3142.57 | 3176.3 | 2873.7 | 2447.4 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 1047.42 | 1099.1 | 1130.3 | 1054.3 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.research-development | 64.97 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.67 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 543.4 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 1.43 | 1.6 | 117.7 | 103.7 | |||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 793.23 | 857.1 | 897.9 | 863.7 | |||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3935.8 | 4033.4 | 3771.6 | 3311.1 | |||||||||||||||||||||||||||
income-statement-row.row.interest-income | 10.21 | 8.7 | 5.4 | 3.1 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 31.84 | 33.9 | 32.9 | 38.6 | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 543.4 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 1.43 | 1.6 | 0.2 | 3.7 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 1.43 | 1.6 | 117.7 | 103.7 | |||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 1.43 | 1.6 | 0.2 | 3.7 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 31.84 | 33.9 | 32.9 | 38.6 | |||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 53.36 | 126.3 | 158.9 | 125.4 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 267.41 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.operating-income | 214.06 | 213.3 | 202.1 | 146 | |||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 215.48 | 214.9 | 202.3 | 149.7 | |||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 57.47 | 57.6 | 51.4 | 40.3 | |||||||||||||||||||||||||||
income-statement-row.row.net-income | 160.27 | 159.3 | 154.4 | 123 |
Häufig gestellte Frage
Wie hoch ist die Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) Gesamtvermögen?
Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) Gesamtvermögen ist 4391320148.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 2172036791.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.250.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.294.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.038.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.051.
Was ist der Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 159285567.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 687763094.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 857067068.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 335906057.000.